|
Insulin, Neurogentics and Memory in Alzheimer's Disease Clinical Trials Data presented on Clinical Trials Search is not meant to be a substitute for qualified health advice, visits or treatment with a real mD. We are not doctors. Always consult your doctor about Insulin, Neurogentics and Memory in Alzheimer's Disease conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Insulin, Neurogentics and Memory in Alzheimer's Disease Clinical research trials and Insulin, Neurogentics and Memory in Alzheimer's Disease healthcare trials happen in many of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally assess the effectivity of new drugs. The purpose of the studies / projects is to solve particular human medical questions. Clinical trials are a popular way for doctors, government agencies, and private sector companies to discover cures for all varieties of conditions, such as Insulin, Neurogentics and Memory in Alzheimer's Disease. Insulin, Neurogentics and Memory in Alzheimer's Disease Clinical Trials and other clinical trials allow volunteers to have health treatment alternatives before they are available to the masses. Some times the human subjects obtain treatment for without cost, and sometimes they are compensated for their time. Occasionally there is a cost for a Insulin, Neurogentics and Memory in Alzheimer's Disease clinical trial. Test subjects oftentimes receive the most effective healthcare possible for their Insulin, Neurogentics and Memory in Alzheimer's Disease condition. Dangers are a reality, however, and may include extra or frequent physician visits, healthcare dangers (possibly life-jeopardising), and/or the treatment being uneffective. Trials are federally governed with rigorous guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "I" Clinical Trials Conditions > Insulin, Neurogentics and Memory in Alzheimer's Disease Insulin, Neurogentics and Memory in Alzheimer's Disease
Insulin, Neurogentics and Memory in Alzheimer's Disease
For Condition: Alzheimer Disease
Status: Recruiting
Sponsor(s): Department of Veterans Affairs Medical Research Service ,
Synopsis: This study examines the use of insulin-sensitizing compounds, as therapeutic agents for cognitive impairment in Alzheimer's disease.
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Efficacy Study
Minimum Age/Maximum Age: 55 Years/80 Years
Genders: Both
Protocol Entry Criteria: Men and women with mild Alzheimer's Disease without serious medical or psychiatric comorbid conditions.
Total Enrollment:
Location and Contact Information:
Overall Study Official:
AlfredFujimoto, ,
VA Puget Sound Health Care System *Recruiting*
Seattle, Washington, 98108
United States
Recruiting Suzanne Craft 206-277-1156
Additional Information:
Study ID Numbers: AGCG-012-98S;
Study Start Date: October 1999
Record last reviewed: June 2001
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00018382
Other Alzheimer Disease Studies:
1. Treating Behavioral Disturbances in Individuals with Dementia
2. Lipitor as a Treatment for Alzheimer's Disease
3. Pain Management and Behavioral Outcomes in Patients with Dementia
4. Healthy Aging and Memory Study
5. Estrogen Protocol
Related Studies:
Other Alzheimer Disease Clinical Trials
Other Washington Clinical Trials
Other Seattle Clinical Trials
Insulin, Neurogentics and Memory in Alzheimer's Disease
|
|
|
|
|
|
|
|